当前位置: 首页 >> 检索结果
共有 7810 条符合本次的查询结果, 用时 2.9795555 秒

441. Differentiation of Prior SARS-CoV-2 Infection and Postacute Sequelae by Standard Clinical Laboratory Measurements in the RECOVER Cohort.

作者: Kristine M Erlandson.;Linda N Geng.;Caitlin A Selvaggi.;Tanayott Thaweethai.;Peter Chen.;Nathan B Erdmann.;Jason D Goldman.;Timothy J Henrich.;Mady Hornig.;Elizabeth W Karlson.;Stuart D Katz.;C Kim.;Sushma K Cribbs.;Adeyinka O Laiyemo.;Rebecca Letts.;Janet Y Lin.;Jai Marathe.;Sairam Parthasarathy.;Thomas F Patterson.;Brittany D Taylor.;Elizabeth R Duffy.;Monika Haack.;Boris Julg.;Gabrielle Maranga.;Carla Hernandez.;Nora G Singer.;Jenny Han.;Priscilla Pemu.;Hassan Brim.;Hassan Ashktorab.;Alexander W Charney.;Juan Wisnivesky.;Jenny J Lin.;Helen Y Chu.;Minjoung Go.;Upinder Singh.;Emily B Levitan.;Paul A Goepfert.;Janko Ž Nikolich.;Harvey Hsu.;Michael J Peluso.;J Daniel Kelly.;Megumi J Okumura.;Valerie J Flaherman.;John G Quigley.;Jerry A Krishnan.;Mary Beth Scholand.;Rachel Hess.;Torri D Metz.;Maged M Costantine.;Dwight J Rouse.;Barbara S Taylor.;Mark P Goldberg.;Gailen D Marshall.;Jeremy Wood.;David Warren.;Leora Horwitz.;Andrea S Foulkes.;Grace A McComsey.; .
来源: Ann Intern Med. 2024年177卷9期1209-1221页
There are currently no validated clinical biomarkers of postacute sequelae of SARS-CoV-2 infection (PASC).

442. Diagnostic Discordance, Uncertainty, and Treatment Ambiguity in Community-Acquired Pneumonia : A National Cohort Study of 115 U.S. Veterans Affairs Hospitals.

作者: Barbara E Jones.;Alec B Chapman.;Jian Ying.;Elizabeth D Rutter.;McKenna R Nevers.;Alden Baker.;Nathan C Dean.;Megan L Fix.;Hardeep Singh.;Karen S Cosby.;Peter A Taber.;Charlene D Weir.;Makoto M Jones.;Matthew H Samore.;Jorie M Butler.
来源: Ann Intern Med. 2024年177卷9期1179-1189页
Evidence-based practice in community-acquired pneumonia often assumes an accurate initial diagnosis.

443. Web Exclusive. Annals On Call - Time-Restricted Eating: How Does It Work?

作者: Robert M Centor.;Nisa M Maruthur.
来源: Ann Intern Med. 2024年177卷8期e2401869OC页

444. In adult inpatients with a UTI, CPOE-based vs. routine stewardship reduced extended-spectrum antibiotic use.

作者: Aaron E Glatt.
来源: Ann Intern Med. 2024年177卷8期JC91页
Gohil SK, Septimus E, Kleinman K, et al. Stewardship prompts to improve antibiotic selection for urinary tract infection: the INSPIRE randomized clinical trial. JAMA. 2024;331:2018-2028. 38639723.

445. Prostate cancer screening with MRI does not differ from PSA only for detection but reduces biopsies and overdiagnosis.

作者: Timothy J Wilt.;Philipp Dahm.
来源: Ann Intern Med. 2024年177卷8期JC94页
Fazekas T, Shim SR, Basile G, et al. Magnetic resonance imaging in prostate cancer screening: a systematic review and meta-analysis. JAMA Oncol. 2024;10:745-754. 38576242.

446. In ILD, a step-up diagnostic strategy vs. immediate surgical biopsy reduced need for unexpected chest tube drainage.

作者: Ami Schattner.
来源: Ann Intern Med. 2024年177卷8期JC93页
Kalverda KA, Ninaber MK, Wijmans L, et al. Transbronchial cryobiopsy followed by as-needed surgical lung biopsy versus immediate surgical lung biopsy for diagnosing interstitial lung disease (the COLD study): a randomised controlled trial. Lancet Respir Med. 2024;12:513-522. 38640934.

447. In acute ICH, minimally invasive surgery improved functional outcome at 180 d.

作者: Bing Yu Chen.;Ken Uchino.
来源: Ann Intern Med. 2024年177卷8期JC92页
Pradilla G, Ratcliff JJ, Hall AJ, et al; ENRICH trial investigators. Trial of early minimally invasive removal of intracerebral hemorrhage. N Engl J Med. 2024;390:1277-1289. 38598795.

448. The Annual Cost of Cancer Screening in the United States.

作者: Michael T Halpern.;Benmei Liu.;Douglas R Lowy.;Samir Gupta.;Jennifer M Croswell.;V Paul Doria-Rose.
来源: Ann Intern Med. 2024年177卷9期1170-1178页
Cancer has substantial health, quality-of-life, and economic impacts. Screening may decrease cancer mortality and treatment costs, but the cost of screening in the United States is unknown.

449. In adult inpatients with pneumonia, CPOE-based vs. routine stewardship reduced extended-spectrum antibiotic use.

作者: Aaron E Glatt.
来源: Ann Intern Med. 2024年177卷8期JC90页
Gohil SK, Septimus E, Kleinman K, et al. Stewardship prompts to improve antibiotic selection for pneumonia: the INSPIRE randomized clinical trial. JAMA. 2024;331:2007-2017. 38639729.

450. After PCI and 1 mo of DAPT for ACS, ticagrelor alone vs. continued DAPT for 11 mo reduced bleeding without increasing MACCE.

作者: Cole Clifford.;Andrew T Yan.
来源: Ann Intern Med. 2024年177卷8期JC86页
Ge Z, Kan J, Gao X, et al; ULTIMATE-DAPT investigators. Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial. Lancet. 2024;403:1866-1878. 38599220.

451. Dollars and Sense: The Cost of Cancer Screening in the United States.

作者: H Gilbert Welch.
来源: Ann Intern Med. 2024年177卷9期1275-1276页

452. Inaccuracy of Pneumonia Diagnosis: The More Things Change, the More They Stay the Same.

作者: Mark L Metersky.;Grant W Waterer.
来源: Ann Intern Med. 2024年177卷9期1277-1278页

453. After PCI in older adults, DAPT for 3 vs. 6 or 12 mo reduces bleeding without increasing NACE or MACE.

作者: Cole Clifford.;Andrew T Yan.
来源: Ann Intern Med. 2024年177卷8期JC87页
Park DY, Hu JR, Jamil Y, et al. Shorter dual antiplatelet therapy for older adults after percutaneous coronary intervention: a systematic review and network meta-analysis. JAMA Netw Open. 2024;7:e244000. 38546647.

454. The Ethics of Cancer Screening Based on Race and Ethnicity.

作者: Duco T Mülder.;James F O'Mahony.;Chyke A Doubeni.;Iris Lansdorp-Vogelaar.;Maartje H N Schermer.
来源: Ann Intern Med. 2024年177卷9期1259-1264页
Racial and ethnic disparities in incidence and mortality are well documented for many types of cancer. As a result, there is understandable policy and clinical interest in race- and ethnicity-based clinical screening guidelines to address cancer health disparities. Despite the theoretical benefits, such proposals do not typically address associated ethical considerations. Using the examples of gastric cancer and esophageal adenocarcinoma, which have demonstrated disparities according to race and ethnicity, this article examines relevant ethical arguments in considering screening based on race and ethnicity. Race- and ethnicity-based clinical preventive care services have the potential to improve the balance of harms and benefits of screening. As a result, programs focused on high-risk racial or ethnic groups could offer a practical alternative to screening the general population, in which the screening yield may be too low to demonstrate sufficient effectiveness. However, designing screening according to socially based categorizations such as race or ethnicity is controversial and has the potential for intersectional stigma related to social identity or other structurally mediated environmental factors. Other ethical considerations include miscategorization, unintended negative effects on health disparities, disregard for underlying risk factors, and the psychological costs of being assigned higher risk. Given the ethical considerations, the practical application of race and ethnicity in cancer screening is most relevant in multicultural countries if and only if alternative proxies are not available. Even in those instances, policymakers and clinicians should carefully address the ethical considerations within the historical and cultural context of the intended population. Further research on alternative proxies, such as social determinants of health and culturally based characteristics, could provide more adequate factors for risk stratification.

455. In ASCVD, an inclisiran-first strategy reduced LDL-C levels and statin discontinuation at 330 d.

作者: Ellis Lader.
来源: Ann Intern Med. 2024年177卷8期JC89页
Koren MJ, Rodriguez F, East C, et al. An "inclisiran first" strategy vs usual care in patients with atherosclerotic cardiovascular disease. J Am Coll Cardiol. 2024;83:1939-1952. 38593947.

456. Trends and Disparities in Ambulatory Follow-Up After Cardiovascular Hospitalizations : A Retrospective Cohort Study.

作者: Timothy S Anderson.;Robert W Yeh.;Shoshana J Herzig.;Edward R Marcantonio.;Laura A Hatfield.;Jeffrey Souza.;Bruce E Landon.
来源: Ann Intern Med. 2024年177卷9期1190-1198页
Timely follow-up after cardiovascular hospitalization is recommended to monitor recovery, titrate medications, and coordinate care.

457. Acetaminophen use during pregnancy was not linked to autism, ADHD, or intellectual disability in offspring.

作者: Emma Worringer.;Kate Rowland.
来源: Ann Intern Med. 2024年177卷8期JC95页
Ahlqvist VH, Sjöqvist H, Dalman C, et al. Acetaminophen use during pregnancy and children's risk of autism, ADHD, and intellectual disability. JAMA. 2024;331:1205-1214. 38592388.

458. In MI with preserved LVEF, long-term β-blocker use vs. no use did not reduce all-cause death or MI at 3.5 y.

作者: Belal Suleiman.;Christopher B Granger.
来源: Ann Intern Med. 2024年177卷8期JC88页
Yndigegn T, Lindahl B, Mars K, et al; REDUCE-AMI Investigators. Beta-blockers after myocardial infarction and preserved ejection fraction. N Engl J Med. 2024;390:1372-1381. 38587241.

459. Pain Reduction With Oral Methotrexate in Knee Osteoarthritis : A Randomized, Placebo-Controlled Clinical Trial.

作者: Sarah R Kingsbury.;Puvan Tharmanathan.;Ada Keding.;Fiona E Watt.;David L Scott.;Edward Roddy.;Fraser Birrell.;Nigel K Arden.;Mike Bowes.;Catherine Arundel.;Michelle Watson.;Sarah J Ronaldson.;Catherine Hewitt.;Michael Doherty.;Robert J Moots.;Terence W O'Neill.;Michael Green.;Gulam Patel.;Toby Garrood.;Christopher J Edwards.;Phil J Walmsley.;Tom Sheeran.;David J Torgerson.;Philip G Conaghan.
来源: Ann Intern Med. 2024年177卷9期1145-1156页
Treatments for osteoarthritis (OA) are limited. Previous small studies suggest that the antirheumatic drug methotrexate may be a potential treatment for OA pain.

460. Physician Humility: A Review and Call to Revive Virtue in Medicine.

作者: Caroline L Matchett.;Ellen L Usher.;John T Ratelle.;Diego A Suarez.;Andrea N Leep Hunderfund.;Ana M Aragon Sierra.;Adam P Sawatsky.
来源: Ann Intern Med. 2024年177卷9期1251-1258页
Physician virtues, including humility, are crucial for shaping a physician's identity and practice. The health care literature offers varied views on humility, and the rising call for discussing virtues as a framing for professional identity formation underscores the need for a clearer understanding of physician humility. This review aimed to develop a cohesive conceptualization of physician humility and to define how it functions in medical practice. To achieve this, a comprehensive search was done across PubMed, Ovid MEDLINE, Web of Science, Embase, ERIC, and PsycInfo, covering all records up to 30 October 2023. Articles were included if they discussed physician humility and excluded if they were unrelated to physician humility, focused on nonphysician health professionals, lacked conceptual depth, or focused solely on cultural humility. An applied thematic analysis was conducted. The results provide a synthesized conceptualization of physician humility across stances toward self, others, and the profession. The included articles identified the pivotal role of physician humility within the following 5 domains of medical practice: learning and professional growth, navigating error, uncertainty tolerance, trust and entrustment, and teamwork and communication. The authors highlight some of the intrapersonal, interpersonal, and sociocontextual challenges to cultivating and practicing physician humility. These findings highlight the importance of promoting humility in shaping physicians' actions, thoughts, and relationships with patients, colleagues, and their profession. Integrating such virtues as humility into medical education is essential for upholding the ideals of the medical profession and cultivating moral agents who engage in self-reflection and embody the principles of exemplary physicians.
共有 7810 条符合本次的查询结果, 用时 2.9795555 秒